Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 14, 2018 - Issue 3
Submit an article Journal homepage
302
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Belimumab and antipneumococcal vaccination in patients with systemic lupus erythematosus

Tudor AzoicaiDepartment of Morpho-functional Sciences, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaView further author information
,
Sabina AntoniuDepartment Medicine II-Nursing, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaView further author information
,
Irina Draga CaruntuDepartment of Morpho-functional Sciences, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaView further author information
,
Doina AzoicaiDepartment of preventive medicine and interdisciplinarity, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaView further author information
,
Ileana AntoheDepartment Medicine II-Nursing, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaView further author information
&
Cristina GavriloviciDepartment Medicine III, University of Medicine and Pharmacy “Grigore T Popa”, Iasi, RomaniaCorrespondence[email protected]
View further author information
Pages 175-177 | Received 02 Dec 2017, Accepted 15 Jan 2018, Published online: 22 Jan 2018

References

  • Human Genome Science Inc. aGC. A study to evaluate the effect of belimumab on vaccine responses in subjects with Systemic Lupus Erythematosus (SLE). In: ClinicalTrials.gov[Internet]. Bethesda(MD): National Library of Medicine (US). 2000-2017 Nov 19. Available from: https://clinicaltrials.gov/ct2/show/NCT01597492?term=NCT01597492&rank=1. NLM Identifier: NCT01597492. 2011 [19.11.2017]
  • Chatham W, Chadha A, Fettiplace J, et al. A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus. Lupus. 2017;26(14):1483–1490.
  • Schurder J, Goulenok T, Jouenne R, et al. Pneumococcal infection in patients with systemic lupus erythematosus. Joint Bone Spine. [Epub ahead of print]. 2017 May 18. pii: S1297-319X(17)30103-3.
  • Luijten RKMAC, Cuppen BVJ, Bijlsma JWJ, et al. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus. 2014;23:1512–1516.
  • Grabar S, Groh M, Bahuaud M, et al. Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study. Vaccine. 2017;35:4877–4885.
  • Greenberg RN, Gurtman A, Frenck RW, et al. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60-64 years of age. Vaccine. 2014;32:2364–2374.
  • Jackson LA, Gurtman A, van Cleeff M, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine. 2013;31:3577–3584.
  • Borba EF, Saad CGS, Pasoto SG, et al. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? Rheumatology. 2012;51:1061–1069.
  • Rubin LG, Levin MJ, Ljungman P, et al. Infectious diseases society of A. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44–100.
  • Nagel J, Saxne T, Geborek P, et al. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine. Lupus. 2017;26:1072–1081.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.